Dobutamine In Dextrose Injection, Solution
Product Images NDC 51662-1705

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dobutamine In Dextrose (NDC 51662-1705). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51662 1705 Source Drug)

This is a description of a medication called Dobutamine in 5% Dextrose Injection. It is a solution used for intravenous use only. Each 100 mL contains 200 mg of dobutamine and other components such as dextrose and stabilizers. The solution is sterile, nonpyrogenic, and should only be used if the solution is clear and the container is undamaged. It is recommended to store the solution at 20°C to 25°C. The medication is distributed by Hospira, Inc. in the USA.*

FDA Label Image

Structure (51662 1705 Structure 2)

FDA Label Image

Structure (51662 1705 Structure)

This text provides the molecular formula and weight of a compound: Cq4Hp3NOzeHCI with a molecular weight of 337.85. This compound contains carbon (C), hydrogen (H), nitrogen (N), oxygen (O), and hydrogen chloride (HCI) elements. The specific structure or name of the compound is not clear from the provided text.*

FDA Label Image

Table (51662 1705 Table 1)

FDA Label Image

Label (51662 1705 1)

This text contains a reference to a manufacturer's insert for a product distributed by HF Acquisition Co., LLC located in Mukilteo, WA 98275. The text indicates that the product is for prescription use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.